Croft K D, Beilin L J, Vandongen R, Rouse I, Masarei J
Department of Medicine, University of Western Australia, Perth.
Atherosclerosis. 1990 Aug;83(2-3):101-9. doi: 10.1016/0021-9150(90)90155-c.
A group of 22 subjects with type IIA hypercholesterolaemia (mean serum cholesterol = 8.3 +/- 0.3 mmol/l) were sex, age and weight matched with 22 control subjects (mean serum cholesterol = 4.5 +/- 0.1 mmol/l). Diastolic blood pressure was significantly higher in hypercholesterolaemic subjects (79.2 +/- 1.4 mm Hg) than in control subjects (71.9 +/- 1.4 mm Hg). While the high cholesterol group had 52% greater thromboxane production in clotted whole blood than controls this difference was not significant, and the platelet aggregation and serotonin secretion response to doses of collagen, ADP and arachidonic acid were similar between the 2 groups. Polymorphonuclear leukocyte (PMN) chemiluminescence (used as a measure of reactive oxygen species production) in response to low doses of the chemotactic-peptide FMLP and opsonized zymosan was significantly greater in high cholesterol subjects compared to their matched controls. The production of platelet activating factor (PAF) by calcium ionophore (2.5 micrograms) stimulated PMN isolated from hypercholesterolaemic subjects (11.5 +/- 1.4 ng/10(6) cells) was significantly greater than PAF production by cells from the control group (8.3 +/- 1.0 ng/10(6) cells). Leukotriene B4 release by PMN in response to calcium ionophore did not differ between the 2 groups. These data suggest a degree of leukocyte activation in hypercholesterolaemic subjects compared to controls with normal cholesterol. In addition, plasma levels of lyso-PAF were higher in high cholesterol subjects (317 +/- 21 ng/ml) compared to their matched controls (271 +/- 18 ng/ml) perhaps indicating increased plasma acetylhydrolase activity in subjects with raised cholesterol levels. Recently described biological activity for lyso PAF suggests a possible role for this substance in atherogenesis.(ABSTRACT TRUNCATED AT 250 WORDS)
选取22名患有IIA型高胆固醇血症的受试者(平均血清胆固醇 = 8.3 ± 0.3 mmol/l),将其与22名对照受试者进行性别、年龄和体重匹配(平均血清胆固醇 = 4.5 ± 0.1 mmol/l)。高胆固醇血症受试者的舒张压(79.2 ± 1.4 mmHg)显著高于对照受试者(71.9 ± 1.4 mmHg)。虽然高胆固醇组凝血全血中血栓素的生成量比对照组高52%,但这种差异并不显著,且两组对不同剂量胶原、ADP和花生四烯酸的血小板聚集及5-羟色胺分泌反应相似。与匹配的对照组相比,高胆固醇受试者对低剂量趋化肽FMLP和调理酵母聚糖产生的多形核白细胞(PMN)化学发光(用作活性氧生成的指标)显著增强。钙离子载体(2.5微克)刺激下,从高胆固醇血症受试者分离出的PMN产生的血小板活化因子(PAF)(11.5 ± 1.4 ng/10⁶细胞)显著高于对照组细胞产生的PAF(8.3 ± 1.0 ng/10⁶细胞)。两组PMN对钙离子载体反应产生的白三烯B4释放无差异。这些数据表明,与胆固醇正常的对照组相比,高胆固醇血症受试者存在一定程度的白细胞活化。此外,高胆固醇受试者的血浆溶血PAF水平(317 ± 21 ng/ml)高于其匹配的对照组(271 ± 18 ng/ml),这可能表明胆固醇水平升高的受试者血浆乙酰水解酶活性增加。最近描述的溶血PAF的生物学活性表明该物质在动脉粥样硬化形成中可能发挥作用。(摘要截选至250词)